Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPPL2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UFL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UMAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
VPS41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930655 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CMTR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF827 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPY19L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF417 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD164 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1IP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C1orf109 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPIN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MACC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYTIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMURF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATPIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on